Showing results (361-370 of 421) with videos related to

Sort By:
Pageof 43
The Journal of Pharmacy and Pharmacology|May 25, 2023
Effect of vinpocetine alone and in combination with enalapril in experimental model of diabetic cardiomyopathy in rats: possible involvement of PDE-1/TGF-β/ Smad 2/3 signalling pathwaysVishal Kumar Vishwakarma, Sadia Shah, Tajpreet Kaur, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|February 4, 2023
High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern IndiaBhaskar Kante, Sudheer Kumar Vuyyuru, Ritu Gupta, et al.
Digestive Diseases and Sciences|January 4, 2020
Acute-on-Chronic Liver Failure in Budd-Chiari Syndrome: Profile and Predictors of OutcomeShalimar, Sanchit Sharma, Shivanand R Gamanagatti, et al.
Cancer Discovery|May 11, 2013
TGF-β signaling in myeloid cells is required for tumor metastasisYanli Pang, Sudheer Kumar Gara, Bhagelu R Achyut, et al.
Journal of Crohn'S & Colitis|October 28, 2025
Pharmacological management of upper gastrointestinal Crohn's disease: a systematic reviewMark Chatto, Dimah Alaskar, Christopher Ma, et al.
Frontiers in Endocrinology|July 30, 2021
Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort StudyKshama Aswath, James Welch, Sriram Gubbi, et al.
Inflammatory Bowel Diseases|July 3, 2026
Patients with Crohn's disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing aloneSudheer Kumar Vuyyuru, Shane W Goodwin, Virginia Solitano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
A Combinatorial Strategy for Targeting <i>BRAF</i> <sup>V600E</sup>-Mutant Cancers with BRAF<sup>V600E</sup> Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib)Chandrayee Ghosh, Suresh Kumar, Yevgeniya Kushchayeva, et al.
Journal of Gastroenterology and Hepatology|May 2, 2022
Minimal risk of lymphoma and non-melanoma skin cancer despite long-term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from northern IndiaMukesh Kumar Ranjan, Bhaskar Kante, Sudheer Kumar Vuyyuru, et al.
International Journal of Colorectal Disease|July 14, 2022
Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel diseaseMukesh Kumar Ranjan, Sudheer Kumar Vuyyuru, Bhaskar Kante, et al.
Pageof 43